Edwards Lifesciences EW Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Europe | $442.6M+8.1% | $409.6M+5.6% | $387.9M+2.6% | $378.2M+10.6% | $341.8M-0.6% | |
| Japan | $90.6M+3.5% | $87.5M-2.9% | $90.1M-5.5% | $95.3M+16.5% | $81.8M-4.8% | |
| Rest of World | $177.8M+7.4% | $165.5M-1.3% | $167.6M-0.8% | $169M+12.5% | $150.2M+4.8% | |
| United States | $937.6M+3.4% | $907M-0.1% | $907.5M+2.0% | $889.7M+6.1% | $838.9M+3.2% | |
| Net Sales by Product | ||||||
| Surgical | $276.2M— | —— | —— | —— | $250.9M— | |
| Transcatheter Aortic Valve Replacement | $1.2B+3.2% | $1.16B+0.9% | $1.15B+1.7% | $1.13B+8.1% | $1.05B+1.0% | |
| Transcatheter Mitral and Tricuspid Therapies | $175.1M+12.5% | $155.7M+7.2% | $145.2M+8.0% | $134.5M+16.8% | $115.2M+9.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Edwards Lifesciences break its business down?
- Edwards Lifesciences (EW) reports net sales by business across 4 parts — Europe, Japan, Rest of World and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Edwards Lifesciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Edwards Lifesciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
